Our work on Myasthenia Gravis
Myasthenia Gravis (MG) is a rare autoimmune disorder characterised by muscle weakness and muscle fatigability.
Patients with this condition experience weakness in arms, legs, facial muscles as well as muscles responsible for breathing.
ME&MG
WHAT WE BUILT
ME&MG is a tool used to objectively assess and monitor key functions affected by Myasthenia Gravis.
FEATURED TESTS
HOW IT'S USED
• 1 research study in USA, Canada, Germany
• 1 observational study in France
SUPPORTED BY
Ad Scientiam
Advanced Data Research
THE CHALLENGE
This heterogeneous and variable disorder poses a challenge when quantifying clinical deficits, particularly for the medical monitoring of patients.
Not being able to objectify the evolution of the symptomatology during the consultation with the patient is an issue
Doctors trust therapists trust patients during unique interrogations, which presents a recall and subjectivity bias that can compromise the doctor's perception of disease status and treatment efficacy.
Symptoms fluctuate overtime in Myasthenia Gravis
The assessment scores used by the doctor during the consultation may not necessarily reflect the real state of the patient as the symptoms experienced in their daily lives.